Selected Publications

• “Debate Over ‘Generic Biologics’ Poses Unique Challenges For Policy Makers,” 19 Washington Legal Foundation Legal Backgrounder, No. 13 (2004).



• “The intersection between patent law and the US drug approval process,” in Building and Enforcing Intellectual Property Value (Globe White Page, London, 2003).



• “Clinical Trials Face Heightened Scrutiny as Science and Commerce Appear to Merge,” 4 J. Biolaw & Business, No. 4 (2001).



• "FDA/Patent Law Intersection: What's New With Hatch-Waxman" in Biotechnology Law:  Biotechnology Patents & Business Strategies in the New Millennium, (Practising Law Institute, 2001).



• Co-author, "The Drug Wars: Generics and Pioneers Once Again Make Their Case to Congress," Boston Bar Association Health Law Section Newsletter (Summer 2001).



• "Encouraging Improved Pesticide Formulations: Data Protection for Inert Ingredients," in Pesticide Formulation and Adjuvant Technology, Foy and Pritchard, eds. (CRC Press 1996).



• “The Chemical Weapons Convention,” The National Law Journal (June 27, 1994).



• “Food Standards and the Quest for Healthier Foods,” in Nutrition Labeling: Issues and Directions for the 1990’s, Porter and Earl, eds. (National Academy Press, 1990).



• Co-author, “Tilting the Balance in Favor of Disclosure: The Scope of the Medical Records Exemption to the Federal Freedom of Information Act,” Food Drug Cosmetic Law Review 17 (1988).